Side-by-side comparison of AI visibility scores, market position, and capabilities
Trade surveillance and compliance monitoring platform for financial services, London UK, raised $25M+. Covers MiFID II, EMIR, and communications surveillance requirements.
SteelEye is a London, United Kingdom-based regulatory technology company founded in 2017 that provides a cloud-native trade surveillance, communications monitoring, and regulatory reporting platform for financial services firms. The company has raised over $25 million and serves broker-dealers, investment managers, and trading firms primarily in the UK and Europe, helping them meet the compliance obligations imposed by MiFID II, EMIR, MAR (Market Abuse Regulation), and related UK FCA requirements.\n\nSteelEye's platform aggregates trading data and communications — including voice, email, chat, and instant messaging — into a unified data environment that supports surveillance, investigation, and regulatory reporting workflows. The system applies behavioral analytics and rule-based alerts to detect potential market abuse, front-running, spoofing, and other prohibited trading behaviors across equities, fixed income, and derivatives markets. Compliance teams use SteelEye's investigation workflow tools to review alerts, document findings, and escalate cases.\n\nThe company differentiates from legacy trade surveillance incumbents through its cloud-native architecture, which offers faster deployment, lower total cost of ownership, and more flexible data ingestion than on-premise surveillance systems. SteelEye's communications surveillance capability is increasingly important as regulators scrutinize off-channel communications and messaging app usage by traders. The company competes with NICE Actimize, Nasdaq Surveillance (formerly Smarts), and Behavox in the trade surveillance and market conduct monitoring market.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.